Indo Us Bio-Tech Limited

Equities

INDOUS6

INE250Z01010

Biotechnology & Medical Research

Market Closed - Bombay S.E. Other stock markets 03:30:56 28/06/2024 pm IST			5-day change	1st Jan Change
210 ^INR	-5.21%		-9.48%	-11.95%

02/05	Indo Us Bio-Tech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI
14/02	Indo Us Bio-Tech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Indo Us Bio-Tech Limited has filed an IPO in the amount of INR 72.93 million.

March 05, 2018 at 10:30 am IST

Indo Us Bio-Tech Limited has filed an IPO in the amount of INR 72.93 million. Security Name: Equity Shares Security Type: Common Stock Securities Offered: 1,430,000 PriceRange: INR 51 Transaction Features: Regulation S

Latest news about Indo Us Bio-Tech Limited

Indo Us Bio-Tech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	02/05	CI
Indo Us Bio-Tech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02	CI
Indo US Signs MoU with Navsari Agricultural University for Seed Production, Hybrid Rice Marketing	04/23/04	MT
Indo US Bio Tech Bags Contract for Supply of Hybrid Vegetable Seeds to Chhattisgarh, India	24/23/24	MT
Indo US Bio Tech Limited Enters into Rate Contract with Chhattisgarh State Seed and Agriculture Development Corporation Limited	24/23/24	CI
Indo US Bio-Tech to Issue Bonus Shares	07/23/07	MT
Indo Us Bio-Tech Limited Reports Earnings Results for the Full Year Ended March 31, 2023	03/23/03	CI
Indo Us Bio-Tech Limited Announces Change in Composition of Committees of the Board	09/23/09	CI
Indo Us Bio-Tech Limited announced that it has received INR 61.0103 million in funding from Improwised Technologies Pvt. Ltd	09/22/09	CI
US Bio-Tech Sells 98.5% Stake in Subsidiary Agripari E-Commerce	29/22/29	MT
Indo Us Bio-Tech Limited Reports Earnings Results for the Full Year Ended March 31, 2022	09/22/09	CI
Indo Us Bio-Tech Limited announced that it expects to receive INR 27.0855 million in funding	21/22/21	CI
Indo Us Bio-Tech Limited Reports Earnings Results for the Half Year Ended September 30, 2021	14/21/14	CI
Indo Us Bio-Tech Limited Declares Dividend	19/21/19	CI
Indo Us Bio-Tech Limited Recommends Dividend	09/21/09	CI
Indo Us Bio-Tech Limited Announces Resignation of Samarth Patel, Non- Executive and Independent Director	05/21/05	CI
976,000 Equity Shares of Indo Us Bio-Tech Limited are subject to a Lock-Up Agreement Ending on 14-MAY-2021.	14/21/14	CI
Indo Us Bio-Tech Limited Announces Resignation of Nidhi Ajudia as Non- Executive and Independent Director	10/21/10	CI
Indo Us Bio-Tech Limited Reports Earnings Results for the Half Year Ended September 30, 2020	13/20/13	CI
Indo Us Bio-Tech Limited Reports Earnings Results for the Full Year Ended March 31, 2020	30/20/30	CI
Indo Us Bio-Tech Limited Announces Appointment of Dimpy Joshi as Company Secretary and Compliance Officer	24/20/24	CI
Indo Us Bio-Tech Limited Announces Board Appointments	14/19/14	CI
Indo Us Bio-Tech Limited Reports Earnings Results for the Half Year Ended September 30, 2019	14/19/14	CI
Indo US Bio-Tech Limited Announces Board Resignations	14/19/14	CI
Indo Us Bio-Tech Limited Approves Resignation of Sangeeta Dilipkumar Narwani as Company Secretary and Compliance Officer	09/19/09	CI

Chart Indo Us Bio-Tech Limited

Duration

Period

More charts

Company Profile

Indo US Bio-Tech Limited is engaged in research and development throw breeding, production of seeds, processing, packing and marketing of hybrid and open pollinated varieties of agricultural crops. It is also engaged in educating the local farmers by demonstration of various cultivated research crops. Its product portfolio includes a diversified variety of agriculture seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, cumin, coriander and others. It has a distribution network in the state of Gujarat, Maharashtra, Madhya Pradesh, Chhattisgarh, Rajasthan, Himanchal Pradesh, Punjab, Bihar, Uttar Pradesh, Karnataka, Jharkhand and others. It also exports to many countries, namely the United States, New Jersey, Palestine, Maimi USA, Cameroon, Kuwait, Sri Lanka and Mauritius.

Sector

Biotechnology & Medical Research

Calendar

12/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
INDO US BIO-TECH LIMITED	-11.95%	5.32Cr
LONZA GROUP AG	+38.65%	3.91TCr
IQVIA HOLDINGS INC.	-8.62%	3.88TCr
ALNYLAM PHARMACEUTICALS, INC.	+26.95%	3.12TCr
ICON PUBLIC LIMITED COMPANY	+10.74%	2.59TCr
CELLTRION, INC.	-13.50%	2.58TCr
UNITED THERAPEUTICS CORPORATION	+44.87%	1.41TCr
MEDPACE HOLDINGS, INC.	+34.36%	1.31TCr
BIO-TECHNE CORPORATION	-7.14%	1.13TCr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-12.61%	1.07TCr

Other Biotechnology & Medical Research